Interestingly, the level of SALL4 expression in the CML-CP (median: 0.093; p=0.213) and CML-CR groups (median: 0.025; p<0.0001) was lower in comparison with the HI group, and the increased SALL4 expression level in the CML-BC group (median: 1.563) was significantly higher than that in the CML-CP (p=0.001) and CML-CR (p<0.0001) groups. This evidence concerns the gene SALL4 and breast cancer.